Atlas Trials

A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)

Clinical trial NCT00130793 · COMPLETED

Trial details

NCT number
NCT00130793
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Herpes Zoster
Start date
2005-08-01
Primary completion
2005-11-01
Enrollment
368

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.